Camp4 Therapeutics Corp (CAMP) stock
CAMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.00+0.14 (+3.63%)
Close on Nov 17, 2026Market cap $251.01MP/E –Yield 0.00%
Camp4 Therapeutics operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Camp4 Therapeutics's operating income for the twelve months ending Jun 30, 2026 was -$52.88M. For fiscal 2025 it was -$52.56M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$52.56M | – |
| FY2024 | Dec 31, 2024 | -$53.09M | – |
| FY2023 | Dec 31, 2023 | -$51.88M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$13.38M | – |
| Q1 FY2026 | Mar 31, 2026 | -$13.07M | – |
| Q4 FY2025 | Dec 31, 2025 | -$12.78M | – |
| Q3 FY2025 | Sep 30, 2025 | -$13.65M | – |
| Q2 FY2025 | Jun 30, 2025 | -$13.03M | – |
| Q1 FY2025 | Mar 31, 2025 | -$13.10M | – |
| Q4 FY2024 | Dec 31, 2024 | -$14.03M | – |
| Q3 FY2024 | Sep 30, 2024 | -$13.52M | – |
| Q2 FY2024 | Jun 30, 2024 | -$12.66M | – |
| Q1 FY2024 | Mar 31, 2024 | -$12.88M | – |
| Q4 FY2023 | Dec 31, 2023 | -$13.48M | – |
| Q3 FY2023 | Sep 30, 2023 | -$12.34M | – |
See a number that looks wrong?